JAZZ vs ROOT · P/E 1988, rev $4.07B vs P/E 14, rev $1.18B
Jazz Pharmaceuticals PLC (JAZZ) versus Root Inc (ROOT) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Root Inc (ROOT) is a insurance - property & casualty company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported ROOT revenue for 2024-12-31 was $1.18B. Net income was $30.9M. Revenue was up 158.6% from 2023-12-31 to 2024-12-31. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. ROOT currently screens at market cap $767.6M and trailing P/E 14.3.
Not investment advice. Open the JAZZ and ROOT stock pages for the full models.
Not investment advice.